ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael H. Schatzlein
Mark B. Orringer
Marvin M. Kirsh
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schatzlein, M. H.
Right arrow Articles by Kirsh, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schatzlein, M. H.
Right arrow Articles by Kirsh, M. M.

Ann Thorac Surg 1981;31:322-324
© 1981 The Society of Thoracic Surgeons

Articles

Scalene Node Biopsy in Pulmonary Carcinoma: When Is It Indicated?

Michael H. Schatzlein, M.D., Suzanne McAuliffe, M.S., Mark B. Orringer, M.D., Marvin M. Kirsh, M.D.*

Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI

Accepted for publication April 14, 1980.

* Address reprint requests to Dr. Kirsh, C-7079 Outpatient Building, University Hospital, Ann Arbor, MI 48109

While there is universal agreement that palpable scalene lymph nodes should be biopsied in the preoperative evaluation of patients with carcinoma of the lung, the role of biopsy of nonpalpable scalene nodes remains unclear. This report evaluates the results of biopsy of nonpalpable scalene lymph nodes in 101 consecutive patients with bronchogenic carcinoma otherwise deemed candidates for pulmonary resection. The overall incidence of biopsy positive for metastatic disease was 8.9%. No patient with a peripheral primary lesion, regardless of size or cell type, had metastasis to scalene nodes. Six of 15 patients with centrally located adenocarcinomas showed scalene node metastasis, while only 1 of 40 patients with central squamous cell carcinomas had a positive scalene biopsy. Bilateral biopsy was no more likely to yield positive information than ipsilateral biopsy alone. We now recommend preoperative biopsy of nonpalpable scalene nodes only in patients with central lesions in whom the cell type is adenocarcinoma or unknown.




This article has been cited by other articles:


Home page
 ThoraxHome page
M Kumaran, R E Benamore, R Vaidhyanath, S Muller, C J Richards, M D Peake, and J J Entwisle
Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer
Thorax, March 1, 2005; 60(3): 229 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
K. Ohno, T. Utsumi, Y. Sasaki, and Y. Suzuki
Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer
Eur J Cardiothorac Surg, April 1, 2004; 25(4): 492 - 496.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. D. Lee and R. J. Ginsberg
Lung Cancer Staging: The Value of Ipsilateral Scalene Lymph Node Biopsy Performed at Mediastinoscopy
Ann. Thorac. Surg., August 1, 1996; 62(2): 338 - 341.
[Abstract] [Full Text]

Home page
 RadiologyHome page
P. J. Fultz, R. H. Feins, J. G. Strang, J. C. Wandtke, D. W. Johnstone, T. J. Watson, R. H. Gottlieb, S. L. Voci, and D. J. Rubens
Detection and Diagnosis of Nonpalpable Supraclavicular Lymph Nodes in Lung Cancer at CT and US
Radiology, January 1, 2002; 222(1): 245 - 251.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1981 by The Society of Thoracic Surgeons.